Schedule 13G ownership disclosure
Capstone Therapeutics Corp.
Security class unavailable · CUSIP: 14068E109
Event date: 2019-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 103,000
- Percent of class
- 0.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-006122
- Form type
- SC 13G
- Filer
- Alimco Financial Corp
- CIK
- CIK 1763340
- Filed
- Feb 11, 2019
- Reporting period
- Feb 11, 2019
- Description
- Schedule 13G beneficial ownership